The Chemours Company (NYSE:CC) Given Consensus Rating of “Hold” by Brokerages

The Chemours Company (NYSE:CC) has been given an average rating of “Hold” by the eight analysts that are presently covering the firm, MarketBeat.com reports. Six equities research analysts have rated the stock with a hold recommendation and two have given a buy recommendation to the company. The average 1 year price target among brokers that have issued ratings on the stock in the last year is $31.63.

A number of equities research analysts have commented on the company. Barclays decreased their price target on Chemours from $32.00 to $30.00 and set an “equal weight” rating for the company in a research note on Tuesday, April 2nd. UBS Group raised their price objective on Chemours from $21.00 to $28.00 and gave the stock a “neutral” rating in a research note on Tuesday, April 2nd. Finally, BMO Capital Markets upgraded Chemours from an “underperform” rating to an “outperform” rating and raised their price objective for the stock from $19.00 to $34.00 in a research note on Tuesday, April 9th.

Institutional Trading of Chemours

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Hexagon Capital Partners LLC acquired a new stake in Chemours in the fourth quarter valued at approximately $25,000. Legacy Financial Group LLC acquired a new stake in Chemours in the third quarter valued at approximately $29,000. Morton Brown Family Wealth LLC acquired a new stake in Chemours in the fourth quarter valued at approximately $35,000. Neo Ivy Capital Management acquired a new stake in Chemours in the fourth quarter valued at approximately $40,000. Finally, Sunbelt Securities Inc. grew its holdings in Chemours by 1,969.7% in the first quarter. Sunbelt Securities Inc. now owns 1,366 shares of the specialty chemicals company’s stock valued at $36,000 after purchasing an additional 1,300 shares during the period. 76.26% of the stock is owned by institutional investors and hedge funds.

Chemours Trading Up 1.1 %

Shares of NYSE CC opened at $27.32 on Tuesday. The business has a fifty day moving average price of $26.70 and a 200 day moving average price of $27.82. The company has a debt-to-equity ratio of 5.40, a current ratio of 1.54 and a quick ratio of 1.00. Chemours has a 1-year low of $15.10 and a 1-year high of $39.05. The stock has a market capitalization of $4.07 billion, a P/E ratio of -17.63 and a beta of 2.00.

Chemours (NYSE:CC) last released its quarterly earnings results on Wednesday, March 27th. The specialty chemicals company reported $0.31 EPS for the quarter, beating analysts’ consensus estimates of $0.29 by $0.02. Chemours had a positive return on equity of 51.73% and a negative net margin of 3.80%. The company had revenue of $1.36 billion during the quarter, compared to analysts’ expectations of $1.37 billion. Equities research analysts expect that Chemours will post 2.23 EPS for the current fiscal year.

Chemours Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, March 15th. Investors of record on Monday, February 26th were issued a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a yield of 3.66%. The ex-dividend date of this dividend was Friday, February 23rd. Chemours’s dividend payout ratio (DPR) is -64.52%.

Chemours Company Profile

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.